Comparison · CMBS vs Life-Co

    CMBS vs life-insurance loan feasibility: how the two largest conventional capital sources actually differ.

    A practical comparison for sponsors with $10M-$75M permanent loans shopping between life-company quotes and CMBS conduit options. The core structural difference — securitization vs balance-sheet hold — cascades into every other underwriting distinction, including who gates the deal, how rigorous documentation must be, and how portable the feasibility study is across alternative lenders.

    Updated for KBRA Property Evaluation Methodology (January 9, 2026), S&P Global CMBS Property Evaluation Methodology Guidance, Fitch U.S. and Canadian Multiborrower Rating Criteria, ACLI 2025-2026 commitment data · 2,400 words

    Structural Difference

    Securitization versus balance-sheet hold.

    The defining structural difference between CMBS conduit and life-insurance permanent loans is hold period and underwriting culture. CMBS conduit pools 30 to 60 individual loans into a single rated securitization, with rating agencies (KBRA, S&P, Fitch, Moody's, DBRS Morningstar) evaluating credit and B-piece buyers (Rialto, KKR, Eightfold, Prime Finance, Ellington) exercising kick-out rights at the bottom of the capital stack. The CMBS originator sells the credit risk into the trust within months of close. Life-insurance companies, by contrast, hold loans on balance sheet for 25 to 30 years. PGIM, MetLife, Northwestern Mutual, Principal, and Pacific Life each underwrite individual deals for the entire amortization period.

    That one structural difference cascades into every other distinction. CMBS underwriting is rating-agency-driven and tends toward standardized documentation that survives B-piece buyer review. Life-co underwriting is relationship-driven and reflects each life-co's individual allocation strategy and credit committee culture. CMBS LTV runs 65 to 75 percent at 1.20 to 1.35x DSCR for conduit deals; life-co LTV runs 55 to 65 percent at 1.30 to 1.50x DSCR with debt yield as a hard threshold at 8 to 10 percent. CMBS prices aggressively for rate; life-co prices conservatively but offers covenants and stability that CMBS does not match.

    Feasibility study scope reflects the structural difference. CMBS feasibility tends toward documentation density that survives rating agency methodology cross-reference and B-piece buyer scrutiny — and tends to be portable across rating agencies if scoped to KBRA-aligned methodology from the outset. Life-co feasibility tends toward narrative density that satisfies an individual underwriter's diligence — and tends to be single-lender by structure. The bankable framework's CMBS-and-life-co scope is built for portability across both contexts.

    Two paths, one structural truth

    • CMBS sells credit risk; life-co holds it

      Defining difference. Cascades into LTV, DSCR, debt yield, documentation, and pricing.

    • B-piece buyers gate CMBS deals

      Rialto, KKR, Eightfold control whether a loan clears into the rated pool. No life-co analog.

    • Life-co is relationship-driven

      PGIM, MetLife, Northwestern Mutual each have individual allocation strategies. Underwriting is more nuanced than CMBS.

    Side-By-Side

    CMBS vs life-co: the comparison.

    Each row covers a dimension where CMBS and life-co underwriting and feasibility scope differ. The rightmost column shows where the difference is structural rather than incidental.

    DimensionCMBS ConduitLife-Insurance CompanyStructural Driver
    Capital structurePooled securitization (30-60 loans)Balance-sheet hold (25-30 years)Securitization vs hold
    Credit oversightRating agencies + B-piece buyersSingle underwriter + credit committeeSecuritization vs hold
    Typical loan size$5M-$75M conduit / $75M+ SASB$10M-$500MMandate scale
    LTV65-75% conduit / 60-75% SASB55-65%Hold-period conservatism
    DSCR1.20-1.35x conduit / 1.15-1.30x SASB1.30-1.50xHold-period conservatism
    Debt yield8-10% (post-2008 second filter)8-10% (hard threshold)Same outcome, different culture
    Pricing postureAggressive (sells risk into pool)Conservative (covenants + stability)Securitization vs hold
    Rate typeFixed at issuanceFixed for full amortizationHold-period stability
    RecourseNon-recourse with bad-boy carve-outsNon-recourse with bad-boy carve-outsSame
    PrepaymentYield maintenance / defeasanceMake-whole / yield maintenanceSimilar friction
    Feasibility expectationsRating-agency-aligned formatLender-narrative-aligned formatSecuritization vs hold
    Document portabilityReusable across rating agenciesOften single-lenderSecuritization vs hold
    Cost band$12,000-$22,000$10,000-$18,000CMBS premium for formatting
    Turnaround4-8 weeks (faster process)6-10 weeks (deeper diligence)Securitization vs hold

    "Structural driver" indicates whether the difference traces to the fundamental securitization-vs-balance-sheet-hold distinction or to incidental factors like mandate scale or culture. Differences flagged structurally are the most important to scope feasibility study format and methodology against.

    CMBS Governance

    Rating agencies and B-piece buyers: who gates a CMBS deal.

    CMBS conduit underwriting routes through two distinct governance layers. The originating lender — typically a money-center bank or specialty CMBS lender — does the initial credit work. The aggregator (often the same bank, sometimes a separate aggregator) assembles 30 to 60 loans into a securitization and engages rating agencies to evaluate the credit. B-piece buyers review the loans at the bottom of the capital stack and exercise kick-out rights — refusing to accept loans they consider weakest credit, which forces the originator to pull those loans out of the pool.

    The two-layer governance structure means CMBS feasibility studies have to satisfy two distinct audiences. Rating agency methodology is published and consistent — KBRA Property Evaluation Methodology updated January 9, 2026; S&P Global CMBS Property Evaluation Methodology Guidance; Fitch U.S. and Canadian Multiborrower Rating Criteria — and a feasibility study scoped to one rating agency's methodology generally satisfies the others. B-piece buyer review is more discretionary and varies by buyer (Rialto's posture differs from KKR's, which differs from Eightfold's). The bankable framework's CMBS scope is built to KBRA methodology with explicit cross-reference to the other major rating agencies, and constructed to survive typical B-piece buyer scrutiny on tenant rollover, transitional credit, and specialty asset class deals.

    Rating Agencies

    • KBRA

      KBRA Property Evaluation Methodology, updated January 9, 2026

    • S&P

      S&P Global CMBS Property Evaluation Methodology Guidance

    • Fitch

      U.S. and Canadian Multiborrower Rating Criteria

    • Moody's

      Approach to Rating U.S. CMBS

    • DBRS Morningstar

      North American CMBS Methodology

    B-Piece Buyers

    • Rialto Capital

      Largest active B-piece buyer; Lennar affiliate

    • KKR Real Estate

      Active across conduit and SASB

    • Eightfold Real Estate Capital

      Specialty B-piece focus

    • Prime Finance

      Conduit B-piece, increasing SASB activity

    • Ellington Management

      Smaller-pool B-piece focus

    Typically two of the five rating agencies rate any given conduit deal. Securitization counsel and aggregator decide which two based on cost, methodology fit, and recent posture toward the asset class. The bankable framework's CMBS scope structures methodology cross-reference for KBRA primary, with secondary alignment to S&P, Fitch, Moody's, and DBRS Morningstar — covering whichever combination is selected.

    Life-Co Underwriting

    Life-co underwriting and allocation patterns 2025-2026.

    Life-insurance company commercial mortgage commitments totaled approximately $80 billion in 2025 ACLI originations, with allocations concentrated among the largest balance-sheet allocators. The structural feature that distinguishes life-co underwriting is single-underwriter scrutiny — a credit officer at PGIM or MetLife reviews the full deal package and the credit committee approves it. There is no rating agency, no B-piece buyer, and no securitization audience to satisfy. The underwriter's individual judgment, the credit committee's culture, and the life-co's published allocation strategy drive the decision.

    Allocation patterns shifted notably through 2025. Industrial allocations grew sharply across most life-co allocators (PGIM particularly heavy in industrial; MetLife diversified institutional; Northwestern Mutual industrial and multifamily; Principal industrial-led; Pacific Life multifamily-led). Multifamily allocations stayed steady. Office allocations declined materially across most allocators with PGIM, MetLife, and Northwestern Mutual all reducing office exposure. Senior housing returned to allocation lists after a multi-year pause. Data center allocations grew sharply across PGIM, MetLife, and TIAA-Nuveen. Hospitality allocations remained selective with Pacific Life and Symetra leading the limited life-co hospitality activity.

    Life-co feasibility studies are structurally different from CMBS feasibility studies. The audience is one underwriter and one credit committee, not a rating agency and a B-piece buyer. Documentation density runs higher on tenant credit analysis and NOI durability under lease rollover scenarios, and lower on the rating-agency-format conventions that CMBS scope requires. Life-co feasibility tends to be single-lender — a study scoped specifically for PGIM is not necessarily reusable for MetLife without modification, because each life-co's credit officer reads the deal through a lens shaped by that life-co's allocation strategy.

    PGIM

    Allocation strategy 2025-2026

    Industrial-heavy. Multifamily steady. Office reduced. Data center growing. Senior housing returning. Largest industrial book in the life-co category.

    MetLife

    Allocation strategy 2025-2026

    Diversified institutional. Industrial up. Multifamily steady. Office reduced. Specialty allocations to senior housing and data center.

    Northwestern Mutual

    Allocation strategy 2025-2026

    Industrial and multifamily focus. Office posture conservative. Data center selective. Generally tighter LTV than peers.

    Principal

    Allocation strategy 2025-2026

    Industrial-led with growing multifamily and senior housing. Office reduced. Selective hospitality. Mid-Atlantic and Sun Belt concentration.

    Feasibility Expectations

    Feasibility study expectations: side-by-side.

    CMBS and life-co feasibility scope diverge most on format, methodology cross-reference, and audience-specific narrative density. The grid below covers the practical differences.

    Format alignment

    CMBS: Rating-agency-format aligned

    LIFE-CO: Lender-narrative-format aligned

    CMBS feasibility scope follows KBRA Property Evaluation Methodology format with explicit cross-reference to S&P, Fitch, Moody's, DBRS. Life-co feasibility follows the originating life-co's preferred narrative depth, often heavier on tenant credit and lease rollover.

    Required for which deal types

    CMBS: Hotel, value-add multifamily, retail with rollover

    LIFE-CO: Construction, lease-up bridge, hospitality, seniors, manufactured housing, student housing, tax-credit affordable

    CMBS pools include institutional and transitional product; feasibility required where comparable analysis is decision-critical. Life-co requires feasibility primarily for construction, transitional, and specialty asset classes where appraisal-only analysis is insufficient.

    Methodology cross-reference

    CMBS: Multiple rating agencies

    LIFE-CO: Single underwriter

    CMBS feasibility cites and cross-references the relevant rating agencies — typically KBRA primary with secondary alignment. Life-co feasibility addresses the originating life-co's specific underwriting framework rather than cross-referencing multiple methodologies.

    B-piece buyer scrutiny

    CMBS: Required to survive

    LIFE-CO: Not applicable

    CMBS feasibility must survive B-piece buyer review — Rialto, KKR, Eightfold each have particular lenses on tenant credit, transitional risk, and specialty asset class diligence. Life-co has no analogous downstream review; the credit committee approves and the deal closes.

    Document portability

    CMBS: Reusable across rating agencies

    LIFE-CO: Often single-lender

    A KBRA-aligned CMBS feasibility study generally satisfies S&P, Fitch, Moody's, and DBRS Morningstar with minor cross-reference additions. A PGIM-scoped life-co feasibility may require modification to fit MetLife's underwriting lens.

    Stabilization status emphasis

    CMBS: Standalone studies for non-stabilized only

    LIFE-CO: Construction and lease-up always require feasibility

    CMBS often accepts MAI appraisal market analysis on stabilized institutional product. Life-co similarly accepts appraisal on stabilized permanent loans but requires feasibility for any construction, lease-up, or transitional credit deal.

    Rating Agency Methodology

    KBRA, S&P, Fitch, Moody's, DBRS — methodology references.

    Each rating agency publishes its property evaluation methodology, which CMBS feasibility scope must align to. The grid below references the current methodology for each agency.

    01

    KBRA

    Current methodology

    KBRA Property Evaluation Methodology, updated January 9, 2026. The most active rating agency in CMBS in 2025-2026. Most CMBS feasibility scoped against this methodology by default.

    02

    S&P

    Current methodology

    S&P Global CMBS Property Evaluation Methodology Guidance. Long-standing methodology with periodic updates. Frequent secondary rating alongside KBRA on conduit deals.

    03

    Fitch

    Current methodology

    U.S. and Canadian Multiborrower Rating Criteria. Methodology focused on multiborrower conduit pools. Active across conduit and SASB.

    04

    Moody's

    Current methodology

    Approach to Rating U.S. CMBS. Methodology emphasis on credit migration and structural finance dynamics. Selective active in 2025-2026.

    05

    DBRS Morningstar

    Current methodology

    North American CMBS Methodology. Active across multiborrower conduit and SASB. Structural finance methodology with broad asset class coverage.

    Typically two of the five rating agencies rate any given conduit deal. Securitization counsel and aggregator select the rating agencies based on cost, methodology fit, and current posture toward the specific asset class. The bankable framework's CMBS feasibility scope structures methodology cross-reference for KBRA primary with secondary alignment to whichever combination is most likely.

    Cost + Turnaround + Portability

    Cost, turnaround, and document portability.

    CMBS scope runs slightly more expensive than life-co scope because of rating-agency formatting overhead. Turnaround runs faster on CMBS because rating agency methodology is standardized; life-co takes longer because each life-co's credit committee culture varies.

    CMBS

    4-8 weeks

    Typical turnaround

    Conduit and SASB. Standardized rating agency format expedites.

    Life-Co

    6-10 weeks

    Typical turnaround

    Single-underwriter diligence. Larger life-cos typically faster.

    CMBS

    $12,000-$22,000

    Cost band

    Rating-agency-format premium. SASB at top of band.

    Life-Co

    $10,000-$18,000

    Cost band

    Lender-narrative format. Larger life-cos sometimes higher.

    Document portability is the dimension where CMBS and life-co scope diverge most consequentially. A KBRA-aligned CMBS feasibility study generally satisfies S&P, Fitch, Moody's, and DBRS Morningstar with minor cross-reference additions, and works across multiple originators (rating agencies are upstream of which lender originates the loan). A life-co-scoped feasibility study tends to be single-lender by structure — a study scoped for PGIM may require modification for MetLife or Northwestern Mutual to address each life-co's specific underwriting lens. For sponsors with multiple lenders potentially bidding, CMBS portability is a structural advantage.

    Asset Class Fit

    Which path wins for which asset class.

    CMBS and life-co don't compete equally across asset classes. Some asset classes structurally fit CMBS; others fit life-co; some fit neither well; multifamily fits the agencies first, with CMBS or life-co as alternatives.

    Hotel

    PRIMARY: CMBS or debt fund

    SECONDARY: Life-co rare except top-tier brands

    Hotel volatility and operational complexity favor CMBS securitization (sells the credit risk) over life-co balance-sheet hold. Life-co activity in hospitality is selective; Pacific Life and Symetra are most active among the life-cos. Hospitality almost always CMBS.

    Multifamily

    PRIMARY: Agency (Fannie DUS, Freddie Optigo)

    SECONDARY: CMBS or life-co

    Agency multifamily wins structurally on rate, LTV, and amortization for stabilized market-rate, workforce, and affordable. CMBS and life-co compete for non-agency-eligible multifamily — value-add transitional, market-rate above agency cap, specialty configurations.

    Industrial

    PRIMARY: Life-co (increasingly aggressive)

    SECONDARY: CMBS conduit

    Life-co allocation increases through 2025-2026 made industrial the most competitive life-co target. PGIM particularly aggressive. CMBS competitive on credit-tenant net lease and rollover-active portfolios. Sponsor often plays both against each other.

    Retail

    PRIMARY: CMBS conduit (with rollover scrutiny)

    SECONDARY: Life-co for grocery-anchored credit-tenant

    CMBS dominates retail conduit issuance, especially mixed-tenancy and rollover-active product. Life-co competitive for grocery-anchored centers with strong anchor credit and longer remaining lease terms.

    Office

    PRIMARY: Trapped between

    SECONDARY: Neither bidding aggressively

    2025-2026 office repricing left both CMBS and life-co cautious. CMBS pricing wide; life-co allocation reduced sharply at PGIM, MetLife, Northwestern Mutual. Sponsors with office-heavy deals frequently default to debt fund or bank financing while waiting for the institutional bid to return.

    Mixed-use

    PRIMARY: CMBS or life-co (configuration dependent)

    SECONDARY: Agency on residential carve-out

    Component-driven decision. Mixed-use multifamily routes residential to agency; commercial to CMBS or life-co. Pure mixed-use without agency-eligible residential typically lands at CMBS for stabilized refinance, life-co for institutional credit-tenant heavy.

    Scoping Approach

    How to scope a feasibility study for both CMBS and life-co audiences.

    Five practical steps for sponsors with deals where CMBS and life-co are both realistically bidding.

    01

    Determine the structural lens

    Hospitality, retail, transitional → CMBS-primary scope. Industrial, credit-tenant, stabilized → life-co-primary scope. Both bidding → dual-scope from the outset.

    02

    Build to KBRA-aligned methodology

    KBRA Property Evaluation Methodology is the structural foundation. Cross-references to S&P, Fitch, Moody's, DBRS Morningstar layer in for portability across rating agencies.

    03

    Add tenant credit and NOI durability depth

    Life-co's narrative density on tenant credit and lease rollover layered onto the CMBS-format foundation. Single deliverable functions as both formats.

    04

    Structure for B-piece buyer survival

    Anticipate Rialto, KKR, Eightfold scrutiny on transitional credit and specialty asset class deals. Surface the analytical questions before B-piece buyers ask them.

    05

    Single certification, multi-audience

    Certification page references KBRA primary methodology, secondary rating agencies, and life-co underwriting standard. Deliverable functions across CMBS conduit, SASB, and life-co contexts.

    Decision Framework

    When CMBS wins vs when life-co wins.

    Practical decision criteria for sponsors choosing between CMBS conduit and life-insurance permanent financing on the same deal.

    When CMBS Wins

    • Higher LTV is necessary

      CMBS at 65-75% LTV beats life-co at 55-65% LTV by 10-15 leverage points. Decisive for sponsors maximizing leverage.

    • Aggressive pricing matters more than covenants

      CMBS prices to sell the credit into the pool, which produces tighter pricing than life-co for clean stabilized institutional product.

    • Document portability across multiple originators

      KBRA-aligned scope works across all rating agencies and across multiple CMBS originators bidding. Maximizes term-sheet competition leverage.

    • Hospitality, retail with rollover, transitional product

      Asset classes where CMBS structurally dominates. Life-co activity selective and pricing wide. CMBS is the practical path.

    • Faster execution priority

      CMBS feasibility runs 4-8 weeks vs life-co 6-10. Time-critical refinances or acquisitions favor CMBS turnaround.

    When Life-Co Wins

    • Long-term hold and rate stability matter

      Life-co holds for 25-30 years with full-amortization fixed rate. CMBS conduit fixed-rate period typically caps at 10 years.

    • Covenant flexibility matters

      Life-co covenants negotiable through credit committee. CMBS covenants rating-agency-driven and inflexible.

    • Industrial credit-tenant and stabilized institutional

      Asset classes where life-co aggressively bid through 2025-2026. PGIM, MetLife, Northwestern Mutual all heavy bidders.

    • Lower LTV is acceptable in exchange for relationship

      Sponsor with strong life-co relationship and tolerance for 55-65% LTV often gets pricing and execution superior to CMBS.

    • Avoiding rating agency and B-piece buyer scrutiny

      Sponsor with regulatory or credit-history sensitivity prefers single-underwriter relationship over multi-audience securitization.

    Both Bidding

    What if both CMBS and life-co are bidding?

    Three scenarios cover most deals where CMBS conduit and life-insurance permanent financing both appear at the term-sheet stage. Each carries a different scoping recommendation.

    Scenario one: Stabilized institutional credit-tenant deal with both CMBS and life-co bidding aggressively. Industrial, credit-tenant office (where any office bidder remains), grocery-anchored retail, and large institutional multifamily above agency caps frequently see this competition. The dual-scope feasibility study satisfies both audiences and preserves term-sheet competition leverage. Sponsors who commission a CMBS-only feasibility lose the ability to credibly take a life-co quote, and vice versa.

    Scenario two: Transitional or specialty asset class with CMBS as primary path and life-co as secondary stabilization takeout. Bridge-to-permanent structures often involve CMBS refinance at stabilization with life-co as alternative path if life-co allocation aligns. The CMBS-primary feasibility scope at construction or value-add stage carries forward to stabilization with refresh; if life-co's posture changes through the bridge period, the feasibility supports either takeout.

    Scenario three: Hospitality, value-add multifamily, or retail-with-rollover where CMBS is the primary path and life-co competition is unlikely. Life-co activity is selective in these asset classes. Single-program CMBS scope is appropriate. The dual-scope premium for life-co compatibility is not justified when life-co is unlikely to be at the table.

    The unifying principle: scope to the most demanding lender at the table, with KBRA-aligned methodology as the structural foundation. CMBS scope is more demanding on rating-agency-format conventions; life-co scope is more demanding on tenant credit and NOI durability narrative depth. The bankable framework's CMBS-and-life-co dual-scope engagements layer both onto a single deliverable.

    Read the bankable framework methodology →

    FAQ

    CMBS vs life-co feasibility frequently asked questions.

    Yes, when scoped to KBRA-aligned methodology with tenant credit and NOI durability narrative depth layered in. The structural foundation is rating-agency methodology cross-reference; the additional life-co narrative addresses single-underwriter scrutiny without conflicting with rating agency format. Single deliverable functions as both formats.

    B-piece buyers (Rialto, KKR, Eightfold) review loans at the bottom of the capital stack and exercise kick-out rights. Their scrutiny focuses on tenant rollover risk, transitional credit, and specialty asset class diligence. CMBS feasibility scope must surface and address these concerns before B-piece buyer review, or the loan risks rejection from the pool. The bankable framework's CMBS scope is structured to anticipate B-piece buyer questions.

    Generally yes, when scoped to KBRA-aligned methodology with secondary cross-references to S&P, Fitch, Moody's, and DBRS Morningstar. Two of the five rating agencies typically rate any conduit deal; pre-aligning to KBRA primary with secondary cross-references covers most combinations the aggregator selects.

    Less than CMBS feasibility studies. Each life-co's underwriting reflects its individual allocation strategy and credit committee culture. A study scoped specifically for PGIM may require modification to fit MetLife's underwriting lens. The dual-scope CMBS-and-life-co structure addresses this — the CMBS-format foundation is portable across life-cos because rating-agency-aligned methodology generally satisfies life-co underwriters as well.

    CMBS-only scope typically prices at $12,000-$22,000. Life-co-only scope typically prices at $10,000-$18,000. Dual-scope CMBS-plus-life-co typically prices at $14,000-$24,000 — modest premium over CMBS-only and 25-40 percent premium over life-co-only. For deals where both lenders are realistically at the table, dual-scope is the cost-efficient path.

    Studies completed before January 9, 2026 may need refresh on specific KBRA citations and methodology cross-references where the update changed prior guidance. The bankable framework's pre-update CMBS studies generally exceeded the prior methodology's documentation density already; targeted refresh sometimes addresses specific citation updates rather than substantive analysis.

    Yes. SASB transactions securitize a single large loan or portfolio independently and typically run $75M-$1B+ scale. Rating agency methodology applies but B-piece buyer review structure differs (SASB B-piece buyers more selective). Documentation density runs deeper because the entire securitization rests on one loan rather than 30-60 pooled loans. SASB feasibility scope typically sits at the top of the CMBS cost band ($18,000-$25,000+) with longer turnaround.

    CMBS feasibility runs 4-8 weeks, with rating agency review and B-piece buyer review adding 4-6 weeks before securitization close. Total CMBS timeline from feasibility commission to closing typically runs 90-150 days. Life-co feasibility runs 6-10 weeks, with credit committee approval adding 30-60 days. Total life-co timeline from feasibility commission to closing runs 90-120 days for clean deals.

    Get a feasibility study formatted for CMBS or life-co underwriting.

    CMBS conduit, SASB, or life-co permanent. Single-program or dual-scope. KBRA-aligned methodology with rating agency cross-reference. 30-minute scoping call. Fixed-fee proposal within 24 hours.

    Or read the conventional pillar · CMBS conduit deep-dive · CMBS SASB deep-dive · Life-co deep-dive · Bankable framework